Medications and doses are often similarly prescribed to older and younger adult patients (Somers 2016). This is a problem that must be viewed as ageist, because pharmacological studies have shown for decades that many medications act differently in older and younger people due to the physiological and pathological changes that accompany ageing. Many medications have different efficacy and safety profiles in younger and older age groups (American Geriatrics Society (AGS) 2015; Fialová and Onder 2009; Pazan et al. 2016). For this reason, treating older adults the same as younger adults when prescribing medication, without respecting age-specific needs in terms of such issues as individual dose adjustments, geriatric drug forms, and geriatric medication management, can be seen as a form of ageism. Among older adults, the selection of medication, dosing schedules, and combined drug regimens, as well as appropriate follow-up and management of medication treatment, should always be age-specific and highly individualized. Unfortunately, this is not a common clinical practice (Fialová and Onder 2009; Petrovic et al. 2016).